Long-term mortality associated with aprotinin following coronary artery bypass graft surgery

JAMA. 2007 Jun 13;297(22):2475-6; author reply 2477. doi: 10.1001/jama.297.22.2475-b.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Aprotinin / adverse effects*
  • Coronary Artery Bypass / mortality*
  • Hemostatics / adverse effects*
  • Humans
  • Risk

Substances

  • Hemostatics
  • Aprotinin